Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-22-013468
Filing Date
2022-05-24
Accepted
2022-05-24 20:58:01
Documents
1
Period of Report
2022-05-20

Document Format Files

Seq Description Document Type Size
1 FORM 4 rdgdoc.html 4  
1 FORM 4 rdgdoc.xml 4 2729
  Complete submission text file 0001437749-22-013468.txt   4181
Mailing Address C/O SIGNAL GENETICS, INC. 5740 FLEET STREET CARLSBAD CA 92008
Business Address
SEYMOUR TAMARA A (Reporting) CIK: 0001288232 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36913 | Film No.: 22958728

Mailing Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747
Business Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747 (321) 939-3416
KEMPHARM, INC (Issuer) CIK: 0001434647 (see all company filings)

EIN.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations